G1 Therapeutics Cash from Operations (TTM) Analysis

G1 Therapeutics Inc (GTHX)

3.725 -0.26 (-6.64%) USD | NASDAQ | Apr 29, 15:29

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	-38.34M
September 30, 2023	-56.18M
June 30, 2023	-66.85M
March 31, 2023	-119.49M
December 31, 2022	-128.62M
September 30, 2022	-132.65M
June 30, 2022	-145.48M
March 31, 2022	-143.41M
December 31, 2021	-132.11M
September 30, 2021	-128.96M
June 30, 2021	-91.24M
March 31, 2021	-83.60M
December 31, 2020	-83.74M
September 30, 2020	-82.24M
June 30, 2020	-111.01M

Date	Value
March 31, 2020	-105.05M
December 31, 2019	-99.57M
September 30, 2019	-90.79M
June 30, 2019	-82.47M
March 31, 2019	-77.74M
December 31, 2018	-74.31M
September 30, 2018	-67.82M
June 30, 2018	-64.77M
March 31, 2018	-59.35M
December 31, 2017	-50.52M
September 30, 2017	-44.98M
June 30, 2017	-36.51M
March 31, 2017	-29.13M
December 31, 2016	-25.14M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-145.48M

Minimum

Jun 2022

-38.34M

Maximum

Dec 2023

-101.15M

Average

-99.57M

Median

Dec 2019

Cash from Operations (TTM) Benchmarks